121 related articles for article (PubMed ID: 23903906)
21. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
22. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
Chinnaiyan P; Huang S; Vallabhaneni G; Armstrong E; Varambally S; Tomlins SA; Chinnaiyan AM; Harari PM
Cancer Res; 2005 Apr; 65(8):3328-35. PubMed ID: 15833866
[TBL] [Abstract][Full Text] [Related]
23. Nimotuzumab enhances the radiosensitivity of cancer cells in vitro by inhibiting radiation-induced DNA damage repair.
Qu YY; Hu SL; Xu XY; Wang RZ; Yu HY; Xu JY; Chen L; Dong GL
PLoS One; 2013; 8(8):e70727. PubMed ID: 23976954
[TBL] [Abstract][Full Text] [Related]
24. AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.
Torres MA; Raju U; Molkentine D; Riesterer O; Milas L; Ang KK
Invest New Drugs; 2011 Aug; 29(4):554-61. PubMed ID: 20119866
[TBL] [Abstract][Full Text] [Related]
25. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway.
Li H; Chen X; Yu Y; Wang Z; Zuo Y; Li S; Yang D; Hu S; Xiang M; Xu Z; Yu Z
Oncol Rep; 2014 Dec; 32(6):2596-604. PubMed ID: 25333332
[TBL] [Abstract][Full Text] [Related]
26. Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma.
Tsai YC; Yeh CH; Tzen KY; Ho PY; Tuan TF; Pu YS; Cheng AL; Cheng JC
Eur J Cancer; 2013 Apr; 49(6):1458-66. PubMed ID: 23153706
[TBL] [Abstract][Full Text] [Related]
27. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
28. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest.
Zhao PJ; Song SC; Du LW; Zhou GH; Ma SL; Li JH; Feng JG; Zhu XH; Jiang H
Mol Med Rep; 2016 Mar; 13(3):2878-84. PubMed ID: 26846193
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.
Mimeault M; Johansson SL; Henichart JP; Depreux P; Batra SK
Mol Cancer Ther; 2010 Mar; 9(3):617-30. PubMed ID: 20179163
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin").
Fukutome M; Maebayashi K; Nasu S; Seki K; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):528-36. PubMed ID: 16965995
[TBL] [Abstract][Full Text] [Related]
31. Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity.
Tanaka T; Munshi A; Brooks C; Liu J; Hobbs ML; Meyn RE
Clin Cancer Res; 2008 Feb; 14(4):1266-73. PubMed ID: 18281562
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin.
Chen WS; Lee YJ; Yu YC; Hsaio CH; Yen JH; Yu SH; Tsai YJ; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1527-35. PubMed ID: 20637980
[TBL] [Abstract][Full Text] [Related]
33. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
34. Early increase of radiation-induced γH2AX foci in a human Ku70/80 knockdown cell line characterized by an enhanced radiosensitivity.
Vandersickel V; Depuydt J; Van Bockstaele B; Perletti G; Philippe J; Thierens H; Vral A
J Radiat Res; 2010; 51(6):633-41. PubMed ID: 21116096
[TBL] [Abstract][Full Text] [Related]
35. Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades.
Mimeault M; Mehta PP; Hauke R; Henichart JP; Depreux P; Lin MF; Batra SK
Growth Factors; 2007 Dec; 25(6):400-16. PubMed ID: 18365871
[TBL] [Abstract][Full Text] [Related]
36. Interaction of radiation and gefitinib on a human lung cancer cell line with mutant EGFR gene in vitro.
Sato Y; Ebara T; Sunaga N; Takahashi T; Nakano T
Anticancer Res; 2012 Nov; 32(11):4877-81. PubMed ID: 23155255
[TBL] [Abstract][Full Text] [Related]
37. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells.
Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H
Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles.
Chu SH; Karri S; Ma YB; Feng DF; Li ZQ
Neuro Oncol; 2013 Jul; 15(7):880-90. PubMed ID: 23519742
[TBL] [Abstract][Full Text] [Related]
39. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.
Shafaee Z; Schmidt H; Du W; Posner M; Weichselbaum R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):765-70. PubMed ID: 16552573
[TBL] [Abstract][Full Text] [Related]
40. Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo.
Zhang T; Zhang L; Zhang T; Fan J; Wu K; Guan Z; Wang X; Li L; Hsieh JT; He D; Guo P
Radiat Res; 2014 Jun; 181(6):641-9. PubMed ID: 24844651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
